Galapagos

Galapagos is a biotechnology company with operations in Europe and the U.S., focused on transforming patient outcomes through innovative science and technology. The company specializes in developing small molecules and cell therapies targeting high unmet medical needs in oncology and immunology. Galapagos aims to anticipate and shape the future of healthcare by creating a deep pipeline of best-in-class therapies and ensuring that their innovations reach those who need them most. With a commitment to sustainability, trust, and transparency, Galapagos operates with a strong patient-centered approach and engages in meaningful collaborations and partnerships, including an alliance with Gilead. Their technology platforms enable scalable and agile discovery and development of differentiated medicines.